Cookies are disabled so parts of this website may not function correctly, read more about cookies and how to enable them here  

Become a member

To apply for SBNS membership click the link below and visit our application page.

Find out more

Patient Information

SBNS is unable to give medical advice or recommend neurosurgeons. Please use an appropriate support group or your GP.

Find out more

Become a Neurosurgeon

The management of neurosurgical patients requires excellent medical and surgical skills, a career in Neurosurgery offers many challenges and rewards.

Find out more

 

PROGRAMME  pdf_icon.gif  As at  22 October   2020 

Please note this programme is subject to minor changes - please check this page on a regular basis in the lead up to the meeting

ABSTRACTS 
Oncology Session pdf_icon.gif
Cranial Session pdf_icon.gif  

FRIDAY 23 OCTOBER 

FULL PROGRAMME

09:45
   

 WELCOME
 Neil Kitchen, Immediate Past President
 Alistair Jenkins, SBNS President 

10:00 11:10

SESSION 1 - UK MULTI-CENTRE CLINICAL TRIALS: ARE THEY PRACTICE CHANGING?

 

Chairs:
Michael Jenkinson,  Professor of Neurosurgery , The Walton Centre NHS Trust, Liverpool, UK
Sophie Camp, Consultant Neurosurgeon Imperial College Healthcare NHS Trust, London, UK

10:00

 


NERVES – Results of the Trial
Nerve Rootblock Versus Surgery -  for the treatment of radicular pain secondary to a prolapsed intervertebral disc herniationNerve Rootblock Versus Surgery -  for the treatment of radicular pain secondary to a prolapsed intervertebral disc herniation
Simon Clark, Consultant Neurosurgeon, The Walton Centre NHS Trust, Liverpool, UK*
due to illness Martin Wilby will not be presenting this talk instead it will be presented by Simon Clark

10:30

DISCUSSION/INTERACTIVE VOITING 

 

Launch of new NIHR Multicentre Trials

10:35
 

MAST
Pharmacological management of seizures post traumatic brain injury

Peter Hutchinson, Professor of Neurosurgery, Addenbrookes’ Hospital, Cambridge, UK 

10:40


STOP’EM
s
urgeons Trial of Prophylaxis for Epilepsy in seizure naïve patients with Meningioma: a randomised controlled trial
Michael Jenkinson, Professor of Neurosurgery, The Walton Centre NHS Trust, Liverpool, UK

10:45


CARE
Cavernomas A Randomised Effectiveness - Active versus conservative management of cavernomas
Rustam Al-Shahi Salman, Professor of Clinical Neurology, Edinburgh Royal Infirmary, Edinburgh, UK

10:50

 

 

RECEDE 
Randomised, phase II trial to investigate feasibility, safety and regeneration-promoting effects of Ibudilast following surgical decompression in cervical degenerative myelopathy   
Mark Kotter, Clinical Lecturer, Cambridge University, UK

10:55

 

 

DENS 
Duration of External Neck Stabilisation- following odontoid fracture in older or frail adults: a randomised controlled trial of collar versus no collar     
Paul Brennan, Senior Clinical Lecturer & Honorary Consultant, Edinburgh Royal Infirmary, Edinburgh, UK

11:00

DISCUSSION  

11:08


Collagen matrix onlay dural grafts come of age at 21
Simon Archibald, Chief Scientist, Integra LifeSciences
Codman Specialty Surgical (A division of Integra LifeSciences)

11:10

REST BREAK

11:30
12:35

SESSION 2 – ONCOLOGY 

 

Chairs
Puneet Plaha, Consultant Neurosurgeon, John Radcliffe Hospital, Oxford 
Anil Varma, Consultant Neruosurgeon, James Cook University Hospital, Middlesbrough 

11:30


GUEST SPEAKER
S
urgery for new and recurrent gliomas: how much makes sense?
Professor Phillipe Schucht, Head of Neurosurgical Oncology, University Hospital Bern, Switzerland

12:00 ABSTRACTS

12:00


Redo craniotomy or Bevacizumab for symptomatic steroid refractory true or pseudo progression following IMRT for Glioblastoma
M. Black, Northern Sydney Cancer Centre, Sydney, Australia

12:08


Accuracy of Perfusion-MRI in differentiating treatment-related change and tumour progression in post-resected glioblastoma
C. Murphy, King's College NHS Foundation Trust, London, UK

12:16


Longitudinal white matter damage association with visuospatial perception after surgical glioblastoma resection 
J. Van Helden, Addenbrooke's Hospital, Cambridge, UK

12:24  

DISCUSSION/INTERACTIVE VOTING 

12:33


Innovation at Stryker – Launch of Sonopet iQ
Nick Scott, Neurosurgical Product Manager,
UK & Ireland, Head and Neck, Stryker UK

  GUEST SPEAKER

12:35


Medical Problems of Musical Masters
Phillip L. Pearl, MD, President, Child Neurology Society, Director of Epilepsy and Clinical Neurophysiology, William G. Lennox Chair,  Boston Children's Hospital, USA

13:00 

REST BREAK
 

13:15

 

 

 

 

 

 

 

 

 



SPONSORS SESSION

BBraun - Miethke ICPicture - M.Scio ICP Viewer Software 

Bk Medical  - See the Complete BK Medical Neurosurgery Portfolio

Brainlab  -Opening new horizons in digital surgery 

Codman  - Choosing the Optimal Material for Cranioplasty – Experience with Custom Bone in the Walton Centre
Catherine McMahon, Walton Centre

Medtronic
MIDAS REX™ MR8™.  ‘This is not just a Drill - This is Advancing Surgical Possibilities

NSK
NSK Primado2 - New P300 Handpiece range

Stryker      
Making Healthcare Better with Stryker Head & Neck

Synaptive
Surgical Management of Brain Tumors Utilizing the Synaptive Approach  
Dr. Constantinos Hadjipanayis – The Mount Sinai Hospital, New York City

14:00 14:45

SESSION 3 – CRANIAL RECONSTRUCTION

 

Chairs
Mark Wilson, Professor  of Brain Injury, Imperial College Hospitals, London 

14:00




GUEST SPEAKER 
Penetrating Brain & Spine Injuries
Brad Harrington, Consultant Neurosurgeon. Stellenbosch and Tygerberg Academic Hospital. Cape Town, South Africa


ABSTRACTS

14.20

The UK Cranioplasty Study and Development of the UK Cranial Reconstruction Registry
D. Fountain, Salford Royal NHS Foundation Trust, Manchester, UK

14:28


15-Year Institutional Retrospective Case Series of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction (MCAI) (2005-2020)
S. Lammy, Institute of Neurological Sciences, Glasgow, UK

14:36

DISCUSSION 

14:43

MIDAS REX™ MR8™.  ‘This is not just a Drill, This is advancing surgical possibilities
Medtronic

  GUEST SPEAKER

14:45

As if we didn’t have enough problems: Covid -19 hits South Africa  
Grahame Feiggen, Professor of Neurosurgery
, Neurosciences Institute University of Cape Town, S.A.

15:10

COFFEE BREAK

15:28


Aesculap Aeos 3D Digital Microscope and PPE
BBraun 

15:30
16:45

SESSION 4 – IMPACT OF COVID-19 ON UK NEUROSURGERY

  Chairs
Katie Gilkes, Consultant Neurosurgeon, The Walton Centre NHS Trust, Liverpool, UK
Christos Tolias, Consultant Neurosurgeon, Kings College Hospital, London, UK
 

15:30

IL-Ra COVID-19 Trial
Andrew King, Prof. of Neurosurgery, Salford Royal NHS Foundation Trust, Manchester, UK 
 

15:45


Results of Oncology COVID-19 Trials 
Stephen Price, Consultant Neurosurgeon Addenbrooke's Hospital, Cambridge, UK
Dan Fountain, Salford Royal NHS Foundation Trust, Manchester, UK

16:05

Results of COVID-19 and Pituitary Surgery Survey; the early days
Nigel Mendoza, Consultant Neurosurgeon, Charing Cross Hospital, London, UK

16:15

How  has Covid-19 impacted on the national neurosurgical waiting list?
(And what can we do about it?)
 Paul Grundy, Consultant Neurosurgeon, University Hospital Southampton,Southampton, UK
16:25

 

Impact of Covid-19 on neurosurgery activity and mortality in the United Kingdom
and Republic of Ireland- A national SBNS and BNTRC study

Manjunath Prasad, James Cook University Hospital, Middlesbrough, UK

16:20

DISCUSSION/INTERACTIVE VOTING 

  GUEST SPEAKER

16:45

Super-massive Black Holes: Monsters at the heart of galaxies 
Sadegh Khochfar, Professor and Chair in Theoretical Astrophysics, University of Edinburgh, Scotland, UK

17:10

CLOSING REMARKS 

  Alistair Jenkins 
President of the SBNS

 

    

 

  

  


          

   

 

 

 

 

 

 

 

 

 


 

Last Updated: 30 November 2020